Equine Herpesvirus-1 Myeloencephalopathy in Mules: Neurologic EHV-1 Signs

Vet Teletriage

Worried this is an emergency? Talk to a vet now.

Sidekick.Vet connects you with licensed veterinary professionals for urgent teletriage — get fast guidance on whether your pet needs emergency care. Just $35, no subscription.

Get Help at Sidekick.Vet →
Quick Answer
  • See your vet immediately. Equine herpesvirus-1 myeloencephalopathy, often called EHM, is the neurologic form of EHV-1 and can progress quickly from fever and mild wobbliness to inability to stand.
  • Common warning signs include fever, hind-end weakness, stumbling, leaning, urine dribbling or trouble urinating, reduced tail tone, and recumbency.
  • Diagnosis usually involves a neurologic exam plus PCR testing on a nasal swab and EDTA whole blood. Your vet may also recommend isolation, repeat testing, and sometimes referral or hospitalization.
  • There is no single cure. Care is supportive and may include anti-inflammatory medication, fluids, bladder management, sling support, and strict nursing care based on severity.
  • Because EHV-1 spreads between equids, one sick mule can become a herd problem. Immediate isolation, temperature checks on exposed animals, and biosecurity matter.
Estimated cost: $350–$12,000

What Is Equine Herpesvirus-1 Myeloencephalopathy in Mules?

See your vet immediately if your mule has sudden weakness, wobbliness, urine dribbling, or trouble rising. Equine herpesvirus-1 myeloencephalopathy, or EHM, is the neurologic form of EHV-1 infection. EHV-1 is a common equine herpesvirus that can affect horses and other equids, including mules. In neurologic cases, the virus damages blood vessels that supply the spinal cord and brain, which can lead to inflammation, clotting, and loss of nerve function.

Many affected equids first have a fever, and some also have mild respiratory signs. Neurologic signs may follow and can range from subtle hind-end incoordination to severe paralysis and recumbency. Urinary problems are especially important clues. A mule may dribble urine, strain, or lose normal bladder control.

EHV-1 is also a herd-level concern, not only an individual patient problem. The virus can spread through nasal secretions, contaminated hands, clothing, buckets, tack, trailers, and shared equipment. Some equids carry the virus in a latent state and can begin shedding again during stress or illness.

Because mules are less studied than horses, your vet will usually apply equine EHV-1 guidance to mule care. That makes early recognition, testing, isolation, and practical nursing support especially important.

Symptoms of Equine Herpesvirus-1 Myeloencephalopathy in Mules

  • Fever, sometimes the only early sign
  • Hind limb weakness or a wobbly gait
  • Stumbling, toe dragging, or crossing the limbs
  • Leaning on walls or fences to keep balance
  • Urine dribbling, trouble urinating, or reduced bladder control
  • Reduced tail tone or decreased sensation around the hindquarters
  • Depression, quiet attitude, or reduced appetite
  • Down and unable to rise

Some mules show only fever at first. Others move from mild incoordination to severe weakness within hours to a couple of days. Urinary changes, loss of tail tone, and rapidly worsening hind-end weakness are especially concerning.

Worry right away if your mule is stumbling, falling, dribbling urine, cannot back normally, or seems too weak to stand safely. Keep the mule quiet, limit movement, separate from other equids, and call your vet immediately. Do not trailer a severely weak mule unless your vet advises it and transport can be done safely.

What Causes Equine Herpesvirus-1 Myeloencephalopathy in Mules?

EHM is caused by infection with equine herpesvirus-1. The neurologic damage does not come from the virus directly attacking every nerve cell. Instead, EHV-1 can infect the lining of blood vessels, leading to vasculitis, clot formation, and reduced blood flow in the spinal cord and sometimes the brain. That is why many affected equids develop hind-end weakness, bladder dysfunction, and loss of coordination.

Transmission usually happens through close contact with infected nasal secretions, but people can also move the virus on hands, clothing, thermometers, lead ropes, water buckets, trailers, and other shared equipment. Newly exposed equids may develop fever before obvious neurologic signs appear.

A major challenge is that EHV-1 can become latent. That means an equid may appear healthy for months or years, then begin shedding virus again during stress, transport, competition, crowding, illness, or other immune stressors. This is one reason outbreaks can seem to appear suddenly.

Not every mule exposed to EHV-1 will develop neurologic disease. Severity likely depends on the strain involved, the amount of exposure, immune status, and individual susceptibility. Your vet can help interpret risk for the rest of the herd and decide which exposed animals need monitoring or testing.

How Is Equine Herpesvirus-1 Myeloencephalopathy in Mules Diagnosed?

Diagnosis starts with your vet's exam, history, and biosecurity assessment. Your vet will ask about fever, travel, new arrivals, recent events, contact with sick equids, and whether any herd mates have respiratory signs, abortion, or neurologic problems. A careful neurologic exam helps determine how severe the deficits are and whether the pattern fits spinal cord disease.

Testing usually includes PCR on a nasal swab and EDTA whole blood. Using both samples improves the chance of finding infection because shedding and viremia can vary over time. In some cases, your vet may repeat testing, especially if the first samples were collected very early or if herd-level decisions depend on the result.

Additional testing may include CBC and chemistry work, cerebrospinal fluid analysis, and sometimes referral imaging or other infectious disease testing to rule out problems such as EPM, West Nile virus, trauma, or spinal compression. If a mule dies or is euthanized, necropsy with central nervous system tissue evaluation may be the only way to confirm EHM definitively.

Because EHV-1 neurologic disease is reportable in some situations and states, your vet may need to contact animal health officials. That is part of protecting nearby equids, not a sign that you did anything wrong.

Treatment Options for Equine Herpesvirus-1 Myeloencephalopathy in Mules

Spectrum of Care means you have options. Here are treatment tiers at different price points.

Budget-Conscious Care

$350–$1,500
Best for: Mules that are still standing, have mild to moderate deficits, and can be safely managed on-farm with close veterinary follow-up.
  • Urgent farm exam and neurologic assessment
  • Isolation from other equids
  • PCR testing on nasal swab and blood when feasible
  • Anti-inflammatory medication chosen by your vet
  • Temperature monitoring and strict stall rest
  • Basic nursing care, deep bedding, assisted feeding and watering
  • Bladder monitoring and manure/urine output tracking
Expected outcome: Fair to good if signs stay mild and the mule remains ambulatory. Prognosis worsens if weakness progresses, bladder function declines, or the mule goes down.
Consider: Lower immediate cost range, but on-farm care may not provide enough support for rapidly worsening neurologic disease. Frequent rechecks may still be needed.

Advanced / Critical Care

$5,000–$12,000
Best for: Severely affected mules, recumbent patients, those unable to urinate normally, or situations where safe on-farm care is not possible.
  • Referral hospitalization or isolation facility care
  • 24-hour nursing and frequent neurologic monitoring
  • Advanced fluid support and intensive bladder care
  • Sling systems, assisted recovery equipment, or padded recovery support
  • Management of recumbency complications such as pressure injury, muscle damage, and aspiration risk
  • Expanded diagnostics and consultation with internal medicine or neurology-focused equine teams
  • End-of-life planning if quality of life or safety becomes poor
Expected outcome: Guarded to poor for recumbent or rapidly progressive cases, though some patients improve with aggressive nursing care. Long-term deficits can remain even after survival.
Consider: Most resource-intensive option. It offers the highest level of monitoring and nursing support, but not every mule is a candidate for transport or prolonged hospitalization.

Cost estimates as of 2026-03. Actual costs vary by location, clinic, and individual case.

Questions to Ask Your Vet About Equine Herpesvirus-1 Myeloencephalopathy in Mules

Bring these questions to your vet appointment to get the most out of your visit.

  1. How strongly do my mule's signs fit EHV-1 myeloencephalopathy versus other neurologic diseases?
  2. Should we test both a nasal swab and blood today, and when would repeat testing make sense?
  3. Does my mule need on-farm care, referral hospitalization, or emergency transport precautions?
  4. What signs would mean the condition is worsening, especially for bladder function or ability to stand?
  5. What biosecurity steps should I start right now for other mules, horses, donkeys, and shared equipment?
  6. How long should exposed equids have temperatures checked, and how often?
  7. What treatment options fit my mule's severity and my practical budget?
  8. If my mule recovers, what residual neurologic problems should I watch for during rehabilitation?

How to Prevent Equine Herpesvirus-1 Myeloencephalopathy in Mules

Prevention starts with biosecurity. Isolate new arrivals before mixing them with the resident herd, avoid sharing water buckets and tack between groups, clean trailers between loads, and wash hands or change gloves after handling each equid when disease is suspected. If any mule or horse develops fever, nasal discharge, or neurologic signs, separate that animal immediately and call your vet.

Temperature monitoring is one of the most practical tools during exposure events. At-risk equids should have temperatures checked twice daily so fever is not missed. During confirmed EHM situations, quarantine and release timing should follow your vet and state animal health guidance. Current AAEP guidance notes that confirmed EHM cases should be isolated and affected premises quarantined for a minimum of 28 days, with monitoring during that period.

Vaccination can still be part of herd planning, but it is important to set expectations. At this time, there is no licensed vaccine labeled specifically to prevent the neurologic form, EHM. Vaccination programs may still help reduce respiratory disease and viral shedding risk in some settings, so your vet may recommend a schedule based on travel, event attendance, and herd traffic.

Stress reduction also matters. Avoid unnecessary commingling, overcrowding, and abrupt transport during outbreaks. Keep records of temperatures, new signs, and animal movement. Fast action often makes the biggest difference for both the sick mule and the rest of the herd.